Cliical Trials: Novel Endpoint Development & Digital Biomarkers

AI, ML and Automation Use-Cases That Unlock Value in Novel Endpoint Development & Digital Biomarkers The burgeoning field of biopharmaceuticals is on the cusp of a transformational shift, primarily driven by the integration of artificial intelligence (AI), machine learning (ML), and automation into clinical trials. This evolution is particularly evident in novel endpoint development and…

Read More “AI, ML and Automation Use-Cases That Unlock Value in Novel Endpoint Development & Digital Biomarkers” »

How Novel Endpoint Development & Digital Biomarkers Supports Precision Medicine and Biomarker-Driven Trials How Novel Endpoint Development & Digital Biomarkers Supports Precision Medicine and Biomarker-Driven Trials In recent years, the use of innovative endpoints and digital biomarkers has gained traction in the landscape of clinical research. As precision medicine evolves, it is vital for clinical…

Read More “How Novel Endpoint Development & Digital Biomarkers Supports Precision Medicine and Biomarker-Driven Trials” »